Loading...
Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer
BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...
Saved in:
Published in: | ESMO Open |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BMJ Publishing Group
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/ https://ncbi.nlm.nih.gov/pubmed/27843607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|